Clinical Trials Begin For New Diabetes Drug
Filed in archive Treatment on July 31, 2006
It seems that diabetes research and treatment inventions never slow down. Which could be considered a good thing, both by patients who may benefit from them, and by the pharmaceutical companies who pocket big bucks from them.
Yet another diabetes medication is on the horizon, an oral treatment designed to treat Type 2. Researchers believe the medicine is an innovation in diabetes treatment.
The mechanism of action of DPP-4 inhibitors is distinct from that of any currently available class of glucose lowering agents.
Sitagliptin is a potent and highly selective DPP-4 inhibitor. DPP-4 inhibitors work by enhancing a natural body process that lowers blood sugar, the incretin system. When blood sugar is elevated, incretins work in two ways to help the body regulate high blood sugar levels: they trigger the pancreas to increase insulin and signal the liver to stop producing glucose.
Would you be willing to try it?
Permalink: Clinical Trials Begin For New Diabetes Drug
Tags: diabetes+treatment diabetes treatment drug trials diabetes+drug begin+diabetes trials+begin
Vote for Clinical Trials Begin For New Diabetes Drug:
|
Rating: 9.00 out of 3 vote(s) cast.
|
Response from:
Tara
(12/17/08 11:19am)
I would be more than interested to participate in the clinical trials to cure type 1 juvenile onset diabetes. I've been suffering with diabetes since I was 11 years old, for 12 years. If there is any hope out there... Words can not express the utter joy and relief that I would feel to finally be cured of this extremely taxing and expensive disease.
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Blogs, Blogging & Blogosphere
Challenges
Developments
Diabetics' Device
Did you know
Diet
Education
Exercise
Family Matters
Friends
Fun
Information
Information about
Inspiration
Interviews
Lifestyle
Misc
News
Notable